The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
Clinical trial NCT04937413 · COMPLETED
Trial details
- NCT number
- NCT04937413
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2023-09-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.